Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosis

Fig. 3

Analysis of genomic alterations between two subtypes. Notes: A Mutation profiles of two subtypes were presented. B The TMB level of patients in both two subtypes was calculated. C The survival rate of patients with different TMB levels was analyzed. D The gistic score of copy number variation of TCGA-STAD was shown. E The gain and loss percentage of copy number variation of TCGA-STAD. F The somatic copy-number alterations (SCNA) levels in two subtypes. G The frequency of autosomal amplification and deletion between patients in LM1 and LM2 was analyzed. H The burden of gain and loss of two subtypes both at the focal and arm levels was shown

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us